TABLE 2.
Variable | Total sample (n = 835), % | Perception of financial burden (n = 79), % | No perception of burden (n = 755), % | p value, χ2 |
---|---|---|---|---|
Currently prescribed asthma medication (% yes) | 72 % | 71 % | 41 % | χ2 = 5.18* |
Quick-relief medication (% yes) | 70 % | 68 % | 40 % | χ2 = 4.41* |
Controller medication (% yes) | 24 % | 32 % | 13 % | χ2 = 7.52** |
Frequency of symptoms | χ2 = 37.79*** | |||
≤2 days/week | 85 % | 61 % | 87 % | |
>2 days/week | 5 % | 10 % | 4 % | |
Daily | 8 % | 21 % | 7 % | |
Throughout the day | 2 % | 8 % | 2 % | |
Asthma control | χ2 = 49.42*** | |||
Well-controlled | 76 % | 44 % | 80 % | |
Not well-controlled | 17 % | 38 % | 15 % | |
Poorly controlled | 7 % | 18 % | 5 % | |
Asthma control of children currently prescribed controller medication (n = 513) | χ2 = 3.27, NS | |||
Well-controlled | 57 % | 42 % | 61 % | |
Not well-controlled | 33 % | 42 % | 31 % | |
Poorly controlled | 10 % | 16 % | 8 % | |
Need controller medication and has not been prescribed by physician | 19 % | 34 % | 17 % | χ2 = 7.37** |
Chi-square tests were performed on clinical variables of interest to identify differences between the groups
NS not significant
*p < 0.05, **p < 0.01, ***p < 0.001, as levels of significance reported